Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,144
archived clinical trials in
Ocular

The Measurement of Intraocular Pressure in Normal Children Under General Anesthesia With and Without Nitrous Oxide and Anesthetic Eye Drops
The Measurement of Intraocular Pressure in Nonglaucomatous Children Under Nitrous Oxide/02/Topical Anesthesia and Sevoflurane/Nitrous Oxide/Topical Anesthesia
Status: Enrolling
Updated:  4/9/2014
Bascom Palmer Eye Hospital
mi
from
Miami, FL
The Measurement of Intraocular Pressure in Normal Children Under General Anesthesia With and Without Nitrous Oxide and Anesthetic Eye Drops
The Measurement of Intraocular Pressure in Nonglaucomatous Children Under Nitrous Oxide/02/Topical Anesthesia and Sevoflurane/Nitrous Oxide/Topical Anesthesia
Status: Enrolling
Updated: 4/9/2014
Bascom Palmer Eye Hospital
mi
from
Miami, FL
Click here to add this to my saved trials
The Measurement of Intraocular Pressure in Normal Children Under General Anesthesia With and Without Nitrous Oxide and Anesthetic Eye Drops
The Measurement of Intraocular Pressure in Nonglaucomatous Children Under Nitrous Oxide/02/Topical Anesthesia and Sevoflurane/Nitrous Oxide/Topical Anesthesia
Status: Enrolling
Updated:  4/9/2014
University of Miami Bascom Palmer Eye Hospital
mi
from
Miami, FL
The Measurement of Intraocular Pressure in Normal Children Under General Anesthesia With and Without Nitrous Oxide and Anesthetic Eye Drops
The Measurement of Intraocular Pressure in Nonglaucomatous Children Under Nitrous Oxide/02/Topical Anesthesia and Sevoflurane/Nitrous Oxide/Topical Anesthesia
Status: Enrolling
Updated: 4/9/2014
University of Miami Bascom Palmer Eye Hospital
mi
from
Miami, FL
Click here to add this to my saved trials
Visual Assessment of DAILIES® AquaComfort Plus® for Astigmatism as Compared to 1-DAY ACUVUE® MOIST® for Astigmatism
DAILIES® AquaComfort Plus® Toric - Comparative Assessment of Visual and Mechanical Performance
Status: Enrolling
Updated:  4/11/2014
Alcon Call Center
mi
from
Fort Worth, TX
Visual Assessment of DAILIES® AquaComfort Plus® for Astigmatism as Compared to 1-DAY ACUVUE® MOIST® for Astigmatism
DAILIES® AquaComfort Plus® Toric - Comparative Assessment of Visual and Mechanical Performance
Status: Enrolling
Updated: 4/11/2014
Alcon Call Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Safety and Efficacy Study of AL-53817 and AL-78843 Ophthalmic Solutions for Allergic Conjunctivitis
A Prospective, Randomized, Double-Masked, Vehicle and Active-Controlled, Safety and Efficacy Study of AL-53817 and AL-78843 Ophthalmic Solutions for the Treatment of Allergic Conjunctivitis in an Environmental Exposure Chamber (EEC) Model
Status: Enrolling
Updated:  4/17/2014
Alcon Call Center
mi
from
Fort Worth, TX
Safety and Efficacy Study of AL-53817 and AL-78843 Ophthalmic Solutions for Allergic Conjunctivitis
A Prospective, Randomized, Double-Masked, Vehicle and Active-Controlled, Safety and Efficacy Study of AL-53817 and AL-78843 Ophthalmic Solutions for the Treatment of Allergic Conjunctivitis in an Environmental Exposure Chamber (EEC) Model
Status: Enrolling
Updated: 4/17/2014
Alcon Call Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Investigation of Maintaining Visual Performance Achieved With Cyclosporine Therapy
Status: Enrolling
Updated:  4/22/2014
Clinical Research Facility
mi
from
Andover, MA
Investigation of Maintaining Visual Performance Achieved With Cyclosporine Therapy
Status: Enrolling
Updated: 4/22/2014
Clinical Research Facility
mi
from
Andover, MA
Click here to add this to my saved trials
Effectiveness of a Marketed One-Step Peroxide Lens Care Solution in Symptomatic Contact Lens Wearers
Effectiveness of a Marketed One-Step Peroxide Lens Care Solution in Symptomatic Contact Lens Wearers
Status: Enrolling
Updated:  4/28/2014
Alcon Call Center
mi
from
Fort Worth, TX
Effectiveness of a Marketed One-Step Peroxide Lens Care Solution in Symptomatic Contact Lens Wearers
Effectiveness of a Marketed One-Step Peroxide Lens Care Solution in Symptomatic Contact Lens Wearers
Status: Enrolling
Updated: 4/28/2014
Alcon Call Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Multifocal High ADD Contact Lens Proof of Concept Trial
Evaluation of Visual Performance With a Multifocal High ADD Soft Contact Lens Design
Status: Enrolling
Updated:  4/28/2014
Alcon Call Center
mi
from
Fort Worth, TX
Multifocal High ADD Contact Lens Proof of Concept Trial
Evaluation of Visual Performance With a Multifocal High ADD Soft Contact Lens Design
Status: Enrolling
Updated: 4/28/2014
Alcon Call Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Phase II/III Study of the Efficacy and Safety of MacuCLEAR MC-1101 in Treating DryAge-Related Macular Degeneration
Phase II/III Study of the Efficacy and Safety of MacuCLEAR MC-1101 1.0% BID in the Treatment of Non-exudative Age-Related Macular Degeneration
Status: Enrolling
Updated:  4/29/2014
Rocky Mountain Retina Consultants
mi
from
Murray, UT
Phase II/III Study of the Efficacy and Safety of MacuCLEAR MC-1101 in Treating DryAge-Related Macular Degeneration
Phase II/III Study of the Efficacy and Safety of MacuCLEAR MC-1101 1.0% BID in the Treatment of Non-exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 4/29/2014
Rocky Mountain Retina Consultants
mi
from
Murray, UT
Click here to add this to my saved trials
Frequent Dosing Regimen of Lucentis for Subjects With Persistent Diabetic Macular Edema Despite Standard antiVEGF Dosing
Frequent Dosing Regimen of Lucentis for Subjects With Persistent Diabetic Macular Edema Despite Standard AntiVEGF Dosing
Status: Enrolling
Updated:  4/30/2014
Raj K. Maturi, MD
mi
from
Indianapolis, IN
Frequent Dosing Regimen of Lucentis for Subjects With Persistent Diabetic Macular Edema Despite Standard antiVEGF Dosing
Frequent Dosing Regimen of Lucentis for Subjects With Persistent Diabetic Macular Edema Despite Standard AntiVEGF Dosing
Status: Enrolling
Updated: 4/30/2014
Raj K. Maturi, MD
mi
from
Indianapolis, IN
Click here to add this to my saved trials
IOP Patterns in Fast Versus Slow Visual Field Progression Patients
A Single Center, Case-control, Open Label Study Assessing Intraocular Pressure Patterns in Patients With Primary Open-angle Glaucoma Experiencing Fast Versus Slow Visual Field Progression
Status: Enrolling
Updated:  5/12/2014
New York Eye & Ear Infirmary
mi
from
New York, NY
IOP Patterns in Fast Versus Slow Visual Field Progression Patients
A Single Center, Case-control, Open Label Study Assessing Intraocular Pressure Patterns in Patients With Primary Open-angle Glaucoma Experiencing Fast Versus Slow Visual Field Progression
Status: Enrolling
Updated: 5/12/2014
New York Eye & Ear Infirmary
mi
from
New York, NY
Click here to add this to my saved trials
Comparative Study of Non-contact Tonometers for Intraocular Pressure and Corneal Cell Thickness Measurements
Comparative Study of the Topcon Tonometers - CT-800, CT-1, CT-1P and TRK-2P to Demonstrate Conformance to ANSI Z80.10-2009 Ophthalmic Instruments -Tonometers, to the FDA Guidance for Industry and FDA Staff, Tonometer-Premarket Notification [510(k)] Submissions, and to the Applicable Supplemental Information Sheet and Comparison of Pachymetry Values for CT-1P and TRK-2P With the Konan CellChek Plus (Predicate)
Status: Enrolling
Updated:  5/12/2014
Andover Eye Associates
mi
from
Andover, MA
Comparative Study of Non-contact Tonometers for Intraocular Pressure and Corneal Cell Thickness Measurements
Comparative Study of the Topcon Tonometers - CT-800, CT-1, CT-1P and TRK-2P to Demonstrate Conformance to ANSI Z80.10-2009 Ophthalmic Instruments -Tonometers, to the FDA Guidance for Industry and FDA Staff, Tonometer-Premarket Notification [510(k)] Submissions, and to the Applicable Supplemental Information Sheet and Comparison of Pachymetry Values for CT-1P and TRK-2P With the Konan CellChek Plus (Predicate)
Status: Enrolling
Updated: 5/12/2014
Andover Eye Associates
mi
from
Andover, MA
Click here to add this to my saved trials
Tolerability of Bimatoprost 0.01% vs Latanoprost Eye Drops
Subjective Patient Assessment Comparing Overall Tolerability and Satisfaction of a Prostaglandin Analogue Including Either Bimatoprost 0.01% or Latanoprost.
Status: Enrolling
Updated:  5/13/2014
Harvard Eye Associates
mi
from
Laguna Hills, CA
Tolerability of Bimatoprost 0.01% vs Latanoprost Eye Drops
Subjective Patient Assessment Comparing Overall Tolerability and Satisfaction of a Prostaglandin Analogue Including Either Bimatoprost 0.01% or Latanoprost.
Status: Enrolling
Updated: 5/13/2014
Harvard Eye Associates
mi
from
Laguna Hills, CA
Click here to add this to my saved trials
Safety and Efficacy Study of DE-110 Ophthalmic Suspension for the Treatment of Dry Eye Disease
A Phase II, Prospective, Randomized, Observer-masked, Parallel-group, Multi-center Study Assessing the Safety and Efficacy of Two Concentrations Compared to Placebo for the Treatment of Dry Eye Disease
Status: Enrolling
Updated:  5/19/2014
Clinical Research Facility
mi
from
Inglewood, CA
Safety and Efficacy Study of DE-110 Ophthalmic Suspension for the Treatment of Dry Eye Disease
A Phase II, Prospective, Randomized, Observer-masked, Parallel-group, Multi-center Study Assessing the Safety and Efficacy of Two Concentrations Compared to Placebo for the Treatment of Dry Eye Disease
Status: Enrolling
Updated: 5/19/2014
Clinical Research Facility
mi
from
Inglewood, CA
Click here to add this to my saved trials
Safety and Efficacy Study of DE-110 Ophthalmic Suspension for the Treatment of Dry Eye Disease
A Phase II, Prospective, Randomized, Observer-masked, Parallel-group, Multi-center Study Assessing the Safety and Efficacy of Two Concentrations Compared to Placebo for the Treatment of Dry Eye Disease
Status: Enrolling
Updated:  5/19/2014
Clinical Research Facility
mi
from
Newport Beach, CA
Safety and Efficacy Study of DE-110 Ophthalmic Suspension for the Treatment of Dry Eye Disease
A Phase II, Prospective, Randomized, Observer-masked, Parallel-group, Multi-center Study Assessing the Safety and Efficacy of Two Concentrations Compared to Placebo for the Treatment of Dry Eye Disease
Status: Enrolling
Updated: 5/19/2014
Clinical Research Facility
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Safety and Efficacy Study of DE-110 Ophthalmic Suspension for the Treatment of Dry Eye Disease
A Phase II, Prospective, Randomized, Observer-masked, Parallel-group, Multi-center Study Assessing the Safety and Efficacy of Two Concentrations Compared to Placebo for the Treatment of Dry Eye Disease
Status: Enrolling
Updated:  5/19/2014
Clinical Research Facility
mi
from
Petaluma, CA
Safety and Efficacy Study of DE-110 Ophthalmic Suspension for the Treatment of Dry Eye Disease
A Phase II, Prospective, Randomized, Observer-masked, Parallel-group, Multi-center Study Assessing the Safety and Efficacy of Two Concentrations Compared to Placebo for the Treatment of Dry Eye Disease
Status: Enrolling
Updated: 5/19/2014
Clinical Research Facility
mi
from
Petaluma, CA
Click here to add this to my saved trials
Safety and Efficacy Study of DE-110 Ophthalmic Suspension for the Treatment of Dry Eye Disease
A Phase II, Prospective, Randomized, Observer-masked, Parallel-group, Multi-center Study Assessing the Safety and Efficacy of Two Concentrations Compared to Placebo for the Treatment of Dry Eye Disease
Status: Enrolling
Updated:  5/19/2014
Clinical Research Facility
mi
from
Torrance, CA
Safety and Efficacy Study of DE-110 Ophthalmic Suspension for the Treatment of Dry Eye Disease
A Phase II, Prospective, Randomized, Observer-masked, Parallel-group, Multi-center Study Assessing the Safety and Efficacy of Two Concentrations Compared to Placebo for the Treatment of Dry Eye Disease
Status: Enrolling
Updated: 5/19/2014
Clinical Research Facility
mi
from
Torrance, CA
Click here to add this to my saved trials
Safety and Efficacy Study of DE-110 Ophthalmic Suspension for the Treatment of Dry Eye Disease
A Phase II, Prospective, Randomized, Observer-masked, Parallel-group, Multi-center Study Assessing the Safety and Efficacy of Two Concentrations Compared to Placebo for the Treatment of Dry Eye Disease
Status: Enrolling
Updated:  5/19/2014
Research Site
mi
from
Bloomfield, CT
Safety and Efficacy Study of DE-110 Ophthalmic Suspension for the Treatment of Dry Eye Disease
A Phase II, Prospective, Randomized, Observer-masked, Parallel-group, Multi-center Study Assessing the Safety and Efficacy of Two Concentrations Compared to Placebo for the Treatment of Dry Eye Disease
Status: Enrolling
Updated: 5/19/2014
Research Site
mi
from
Bloomfield, CT
Click here to add this to my saved trials
Safety and Efficacy Study of DE-110 Ophthalmic Suspension for the Treatment of Dry Eye Disease
A Phase II, Prospective, Randomized, Observer-masked, Parallel-group, Multi-center Study Assessing the Safety and Efficacy of Two Concentrations Compared to Placebo for the Treatment of Dry Eye Disease
Status: Enrolling
Updated:  5/19/2014
Clinical Research Facility
mi
from
Bradenton, FL
Safety and Efficacy Study of DE-110 Ophthalmic Suspension for the Treatment of Dry Eye Disease
A Phase II, Prospective, Randomized, Observer-masked, Parallel-group, Multi-center Study Assessing the Safety and Efficacy of Two Concentrations Compared to Placebo for the Treatment of Dry Eye Disease
Status: Enrolling
Updated: 5/19/2014
Clinical Research Facility
mi
from
Bradenton, FL
Click here to add this to my saved trials
Safety and Efficacy Study of DE-110 Ophthalmic Suspension for the Treatment of Dry Eye Disease
A Phase II, Prospective, Randomized, Observer-masked, Parallel-group, Multi-center Study Assessing the Safety and Efficacy of Two Concentrations Compared to Placebo for the Treatment of Dry Eye Disease
Status: Enrolling
Updated:  5/19/2014
Clinical Research Facility
mi
from
Brooksville, FL
Safety and Efficacy Study of DE-110 Ophthalmic Suspension for the Treatment of Dry Eye Disease
A Phase II, Prospective, Randomized, Observer-masked, Parallel-group, Multi-center Study Assessing the Safety and Efficacy of Two Concentrations Compared to Placebo for the Treatment of Dry Eye Disease
Status: Enrolling
Updated: 5/19/2014
Clinical Research Facility
mi
from
Brooksville, FL
Click here to add this to my saved trials
Safety and Efficacy Study of DE-110 Ophthalmic Suspension for the Treatment of Dry Eye Disease
A Phase II, Prospective, Randomized, Observer-masked, Parallel-group, Multi-center Study Assessing the Safety and Efficacy of Two Concentrations Compared to Placebo for the Treatment of Dry Eye Disease
Status: Enrolling
Updated:  5/19/2014
Clinical Research Facility
mi
from
Largo, FL
Safety and Efficacy Study of DE-110 Ophthalmic Suspension for the Treatment of Dry Eye Disease
A Phase II, Prospective, Randomized, Observer-masked, Parallel-group, Multi-center Study Assessing the Safety and Efficacy of Two Concentrations Compared to Placebo for the Treatment of Dry Eye Disease
Status: Enrolling
Updated: 5/19/2014
Clinical Research Facility
mi
from
Largo, FL
Click here to add this to my saved trials
Safety and Efficacy Study of DE-110 Ophthalmic Suspension for the Treatment of Dry Eye Disease
A Phase II, Prospective, Randomized, Observer-masked, Parallel-group, Multi-center Study Assessing the Safety and Efficacy of Two Concentrations Compared to Placebo for the Treatment of Dry Eye Disease
Status: Enrolling
Updated:  5/19/2014
mi
from
Rosewell, GA
Safety and Efficacy Study of DE-110 Ophthalmic Suspension for the Treatment of Dry Eye Disease
A Phase II, Prospective, Randomized, Observer-masked, Parallel-group, Multi-center Study Assessing the Safety and Efficacy of Two Concentrations Compared to Placebo for the Treatment of Dry Eye Disease
Status: Enrolling
Updated: 5/19/2014
mi
from
Rosewell, GA
Click here to add this to my saved trials
Safety and Efficacy Study of DE-110 Ophthalmic Suspension for the Treatment of Dry Eye Disease
A Phase II, Prospective, Randomized, Observer-masked, Parallel-group, Multi-center Study Assessing the Safety and Efficacy of Two Concentrations Compared to Placebo for the Treatment of Dry Eye Disease
Status: Enrolling
Updated:  5/19/2014
Clinical Research Facility
mi
from
Louisville, KY
Safety and Efficacy Study of DE-110 Ophthalmic Suspension for the Treatment of Dry Eye Disease
A Phase II, Prospective, Randomized, Observer-masked, Parallel-group, Multi-center Study Assessing the Safety and Efficacy of Two Concentrations Compared to Placebo for the Treatment of Dry Eye Disease
Status: Enrolling
Updated: 5/19/2014
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
Safety and Efficacy Study of DE-110 Ophthalmic Suspension for the Treatment of Dry Eye Disease
A Phase II, Prospective, Randomized, Observer-masked, Parallel-group, Multi-center Study Assessing the Safety and Efficacy of Two Concentrations Compared to Placebo for the Treatment of Dry Eye Disease
Status: Enrolling
Updated:  5/19/2014
Clinical Research Facility
mi
from
Bangor, ME
Safety and Efficacy Study of DE-110 Ophthalmic Suspension for the Treatment of Dry Eye Disease
A Phase II, Prospective, Randomized, Observer-masked, Parallel-group, Multi-center Study Assessing the Safety and Efficacy of Two Concentrations Compared to Placebo for the Treatment of Dry Eye Disease
Status: Enrolling
Updated: 5/19/2014
Clinical Research Facility
mi
from
Bangor, ME
Click here to add this to my saved trials
Safety and Efficacy Study of DE-110 Ophthalmic Suspension for the Treatment of Dry Eye Disease
A Phase II, Prospective, Randomized, Observer-masked, Parallel-group, Multi-center Study Assessing the Safety and Efficacy of Two Concentrations Compared to Placebo for the Treatment of Dry Eye Disease
Status: Enrolling
Updated:  5/19/2014
Clinical Research Facility
mi
from
Cleveland, OH
Safety and Efficacy Study of DE-110 Ophthalmic Suspension for the Treatment of Dry Eye Disease
A Phase II, Prospective, Randomized, Observer-masked, Parallel-group, Multi-center Study Assessing the Safety and Efficacy of Two Concentrations Compared to Placebo for the Treatment of Dry Eye Disease
Status: Enrolling
Updated: 5/19/2014
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Safety and Efficacy Study of DE-110 Ophthalmic Suspension for the Treatment of Dry Eye Disease
A Phase II, Prospective, Randomized, Observer-masked, Parallel-group, Multi-center Study Assessing the Safety and Efficacy of Two Concentrations Compared to Placebo for the Treatment of Dry Eye Disease
Status: Enrolling
Updated:  5/19/2014
Clinical Research Facility
mi
from
San Antonio, TX
Safety and Efficacy Study of DE-110 Ophthalmic Suspension for the Treatment of Dry Eye Disease
A Phase II, Prospective, Randomized, Observer-masked, Parallel-group, Multi-center Study Assessing the Safety and Efficacy of Two Concentrations Compared to Placebo for the Treatment of Dry Eye Disease
Status: Enrolling
Updated: 5/19/2014
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Safety and Efficacy Study of DE-110 Ophthalmic Suspension for the Treatment of Dry Eye Disease
A Phase II, Prospective, Randomized, Observer-masked, Parallel-group, Multi-center Study Assessing the Safety and Efficacy of Two Concentrations Compared to Placebo for the Treatment of Dry Eye Disease
Status: Enrolling
Updated:  5/19/2014
Clinical Research Facility
mi
from
Norfolk, VA
Safety and Efficacy Study of DE-110 Ophthalmic Suspension for the Treatment of Dry Eye Disease
A Phase II, Prospective, Randomized, Observer-masked, Parallel-group, Multi-center Study Assessing the Safety and Efficacy of Two Concentrations Compared to Placebo for the Treatment of Dry Eye Disease
Status: Enrolling
Updated: 5/19/2014
Clinical Research Facility
mi
from
Norfolk, VA
Click here to add this to my saved trials
Eye Injections of Bevacizumab to See if Medication Helps to Lower Risk of Scar Tissue Development in the Retina and Repeated Retinal Detachment.
A Prospective Pilot Study Evaluating the Effect of Intravitreal Injection of Bevacizumab on Recurrent Retinal Detachment Due to Proliferative Vitreoretinopathy
Status: Enrolling
Updated:  5/27/2014
Mid Atlantic Retina- Wills Eye Institute
mi
from
Philadelphia, PA
Eye Injections of Bevacizumab to See if Medication Helps to Lower Risk of Scar Tissue Development in the Retina and Repeated Retinal Detachment.
A Prospective Pilot Study Evaluating the Effect of Intravitreal Injection of Bevacizumab on Recurrent Retinal Detachment Due to Proliferative Vitreoretinopathy
Status: Enrolling
Updated: 5/27/2014
Mid Atlantic Retina- Wills Eye Institute
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Topical Brinzolamide Ophthalmic Suspension Versus Placebo in the Treatment of Infantile Nystagmus Syndrome
Topical Brinzolamide Ophthalmic Suspension Versus Placebo in the Treatment of Infantile Nystagmus Syndrome
Status: Enrolling
Updated:  6/24/2014
Akron Children's Hospital
mi
from
Akron, OH
Topical Brinzolamide Ophthalmic Suspension Versus Placebo in the Treatment of Infantile Nystagmus Syndrome
Topical Brinzolamide Ophthalmic Suspension Versus Placebo in the Treatment of Infantile Nystagmus Syndrome
Status: Enrolling
Updated: 6/24/2014
Akron Children's Hospital
mi
from
Akron, OH
Click here to add this to my saved trials
6-Week Proof-of-Concept Study of Travoprost/Brinzolamide Ophthalmic Suspension in Subjects With Open-Angle Glaucoma or Ocular Hypertension
A 6-Week Proof-of-Concept Study Evaluating the Safety and IOP-Lowering Efficacy of Travoprost/Brinzolamide Fixed Combination Ophthalmic Suspension in Subjects With Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  6/24/2014
Alcon Call Center
mi
from
Fort Worth, TX
6-Week Proof-of-Concept Study of Travoprost/Brinzolamide Ophthalmic Suspension in Subjects With Open-Angle Glaucoma or Ocular Hypertension
A 6-Week Proof-of-Concept Study Evaluating the Safety and IOP-Lowering Efficacy of Travoprost/Brinzolamide Fixed Combination Ophthalmic Suspension in Subjects With Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 6/24/2014
Alcon Call Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Ustekinumab for Active Sight-Threatening Uveitis
A Pilot Study to Investigate Ustekinumab (StelaraTM) for the Treatment of Active Sight-Threatening Uveitis
Status: Enrolling
Updated:  7/2/2014
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Ustekinumab for Active Sight-Threatening Uveitis
A Pilot Study to Investigate Ustekinumab (StelaraTM) for the Treatment of Active Sight-Threatening Uveitis
Status: Enrolling
Updated: 7/2/2014
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Click here to add this to my saved trials
Phase 3 Study of EBI-005 in Dry Eye Disease
A Multi-Center, Double-Masked, Randomized, Controlled, Efficacy and Safety Study of EBI-005 5 mg/mL Topical Ophthalmic Solution Versus Vehicle Contraol In Subjects With Moderate to Severe Dry Eye Disease
Status: Enrolling
Updated:  7/10/2014
Clinical Research Facility
mi
from
Kansas City, MO
Phase 3 Study of EBI-005 in Dry Eye Disease
A Multi-Center, Double-Masked, Randomized, Controlled, Efficacy and Safety Study of EBI-005 5 mg/mL Topical Ophthalmic Solution Versus Vehicle Contraol In Subjects With Moderate to Severe Dry Eye Disease
Status: Enrolling
Updated: 7/10/2014
Clinical Research Facility
mi
from
Kansas City, MO
Click here to add this to my saved trials
Phase 3 Study of EBI-005 in Dry Eye Disease
A Multi-Center, Double-Masked, Randomized, Controlled, Efficacy and Safety Study of EBI-005 5 mg/mL Topical Ophthalmic Solution Versus Vehicle Contraol In Subjects With Moderate to Severe Dry Eye Disease
Status: Enrolling
Updated:  7/10/2014
Clinical Research Facility
mi
from
Artesia, CA
Phase 3 Study of EBI-005 in Dry Eye Disease
A Multi-Center, Double-Masked, Randomized, Controlled, Efficacy and Safety Study of EBI-005 5 mg/mL Topical Ophthalmic Solution Versus Vehicle Contraol In Subjects With Moderate to Severe Dry Eye Disease
Status: Enrolling
Updated: 7/10/2014
Clinical Research Facility
mi
from
Artesia, CA
Click here to add this to my saved trials
Phase 3 Study of EBI-005 in Dry Eye Disease
A Multi-Center, Double-Masked, Randomized, Controlled, Efficacy and Safety Study of EBI-005 5 mg/mL Topical Ophthalmic Solution Versus Vehicle Contraol In Subjects With Moderate to Severe Dry Eye Disease
Status: Enrolling
Updated:  7/10/2014
Clinical Research Facility
mi
from
Mission Hills, CA
Phase 3 Study of EBI-005 in Dry Eye Disease
A Multi-Center, Double-Masked, Randomized, Controlled, Efficacy and Safety Study of EBI-005 5 mg/mL Topical Ophthalmic Solution Versus Vehicle Contraol In Subjects With Moderate to Severe Dry Eye Disease
Status: Enrolling
Updated: 7/10/2014
Clinical Research Facility
mi
from
Mission Hills, CA
Click here to add this to my saved trials
Phase 3 Study of EBI-005 in Dry Eye Disease
A Multi-Center, Double-Masked, Randomized, Controlled, Efficacy and Safety Study of EBI-005 5 mg/mL Topical Ophthalmic Solution Versus Vehicle Contraol In Subjects With Moderate to Severe Dry Eye Disease
Status: Enrolling
Updated:  7/10/2014
Clinical Research Facility
mi
from
Petaluma, CA
Phase 3 Study of EBI-005 in Dry Eye Disease
A Multi-Center, Double-Masked, Randomized, Controlled, Efficacy and Safety Study of EBI-005 5 mg/mL Topical Ophthalmic Solution Versus Vehicle Contraol In Subjects With Moderate to Severe Dry Eye Disease
Status: Enrolling
Updated: 7/10/2014
Clinical Research Facility
mi
from
Petaluma, CA
Click here to add this to my saved trials
Phase 3 Study of EBI-005 in Dry Eye Disease
A Multi-Center, Double-Masked, Randomized, Controlled, Efficacy and Safety Study of EBI-005 5 mg/mL Topical Ophthalmic Solution Versus Vehicle Contraol In Subjects With Moderate to Severe Dry Eye Disease
Status: Enrolling
Updated:  7/10/2014
Clinical Research Facility
mi
from
Rancho Cordova, CA
Phase 3 Study of EBI-005 in Dry Eye Disease
A Multi-Center, Double-Masked, Randomized, Controlled, Efficacy and Safety Study of EBI-005 5 mg/mL Topical Ophthalmic Solution Versus Vehicle Contraol In Subjects With Moderate to Severe Dry Eye Disease
Status: Enrolling
Updated: 7/10/2014
Clinical Research Facility
mi
from
Rancho Cordova, CA
Click here to add this to my saved trials
Phase 3 Study of EBI-005 in Dry Eye Disease
A Multi-Center, Double-Masked, Randomized, Controlled, Efficacy and Safety Study of EBI-005 5 mg/mL Topical Ophthalmic Solution Versus Vehicle Contraol In Subjects With Moderate to Severe Dry Eye Disease
Status: Enrolling
Updated:  7/10/2014
Clinical Research Facility
mi
from
Torrence, CA
Phase 3 Study of EBI-005 in Dry Eye Disease
A Multi-Center, Double-Masked, Randomized, Controlled, Efficacy and Safety Study of EBI-005 5 mg/mL Topical Ophthalmic Solution Versus Vehicle Contraol In Subjects With Moderate to Severe Dry Eye Disease
Status: Enrolling
Updated: 7/10/2014
Clinical Research Facility
mi
from
Torrence, CA
Click here to add this to my saved trials
Phase 3 Study of EBI-005 in Dry Eye Disease
A Multi-Center, Double-Masked, Randomized, Controlled, Efficacy and Safety Study of EBI-005 5 mg/mL Topical Ophthalmic Solution Versus Vehicle Contraol In Subjects With Moderate to Severe Dry Eye Disease
Status: Enrolling
Updated:  7/10/2014
Clinical Research Facility
mi
from
Littleton, CO
Phase 3 Study of EBI-005 in Dry Eye Disease
A Multi-Center, Double-Masked, Randomized, Controlled, Efficacy and Safety Study of EBI-005 5 mg/mL Topical Ophthalmic Solution Versus Vehicle Contraol In Subjects With Moderate to Severe Dry Eye Disease
Status: Enrolling
Updated: 7/10/2014
Clinical Research Facility
mi
from
Littleton, CO
Click here to add this to my saved trials
Phase 3 Study of EBI-005 in Dry Eye Disease
A Multi-Center, Double-Masked, Randomized, Controlled, Efficacy and Safety Study of EBI-005 5 mg/mL Topical Ophthalmic Solution Versus Vehicle Contraol In Subjects With Moderate to Severe Dry Eye Disease
Status: Enrolling
Updated:  7/10/2014
Clinical Research Facility
mi
from
Roswell, GA
Phase 3 Study of EBI-005 in Dry Eye Disease
A Multi-Center, Double-Masked, Randomized, Controlled, Efficacy and Safety Study of EBI-005 5 mg/mL Topical Ophthalmic Solution Versus Vehicle Contraol In Subjects With Moderate to Severe Dry Eye Disease
Status: Enrolling
Updated: 7/10/2014
Clinical Research Facility
mi
from
Roswell, GA
Click here to add this to my saved trials
Phase 3 Study of EBI-005 in Dry Eye Disease
A Multi-Center, Double-Masked, Randomized, Controlled, Efficacy and Safety Study of EBI-005 5 mg/mL Topical Ophthalmic Solution Versus Vehicle Contraol In Subjects With Moderate to Severe Dry Eye Disease
Status: Enrolling
Updated:  7/10/2014
Clinical Research Facility
mi
from
Bloomingdale, IL
Phase 3 Study of EBI-005 in Dry Eye Disease
A Multi-Center, Double-Masked, Randomized, Controlled, Efficacy and Safety Study of EBI-005 5 mg/mL Topical Ophthalmic Solution Versus Vehicle Contraol In Subjects With Moderate to Severe Dry Eye Disease
Status: Enrolling
Updated: 7/10/2014
Clinical Research Facility
mi
from
Bloomingdale, IL
Click here to add this to my saved trials
Phase 3 Study of EBI-005 in Dry Eye Disease
A Multi-Center, Double-Masked, Randomized, Controlled, Efficacy and Safety Study of EBI-005 5 mg/mL Topical Ophthalmic Solution Versus Vehicle Contraol In Subjects With Moderate to Severe Dry Eye Disease
Status: Enrolling
Updated:  7/10/2014
Clinical Research Facility
mi
from
Indianapolis, IN
Phase 3 Study of EBI-005 in Dry Eye Disease
A Multi-Center, Double-Masked, Randomized, Controlled, Efficacy and Safety Study of EBI-005 5 mg/mL Topical Ophthalmic Solution Versus Vehicle Contraol In Subjects With Moderate to Severe Dry Eye Disease
Status: Enrolling
Updated: 7/10/2014
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Phase 3 Study of EBI-005 in Dry Eye Disease
A Multi-Center, Double-Masked, Randomized, Controlled, Efficacy and Safety Study of EBI-005 5 mg/mL Topical Ophthalmic Solution Versus Vehicle Contraol In Subjects With Moderate to Severe Dry Eye Disease
Status: Enrolling
Updated:  7/10/2014
Clinical Research Facility
mi
from
New Albany, IN
Phase 3 Study of EBI-005 in Dry Eye Disease
A Multi-Center, Double-Masked, Randomized, Controlled, Efficacy and Safety Study of EBI-005 5 mg/mL Topical Ophthalmic Solution Versus Vehicle Contraol In Subjects With Moderate to Severe Dry Eye Disease
Status: Enrolling
Updated: 7/10/2014
Clinical Research Facility
mi
from
New Albany, IN
Click here to add this to my saved trials
Phase 3 Study of EBI-005 in Dry Eye Disease
A Multi-Center, Double-Masked, Randomized, Controlled, Efficacy and Safety Study of EBI-005 5 mg/mL Topical Ophthalmic Solution Versus Vehicle Contraol In Subjects With Moderate to Severe Dry Eye Disease
Status: Enrolling
Updated:  7/10/2014
Clinical Research Facility
mi
from
Lexington, KY
Phase 3 Study of EBI-005 in Dry Eye Disease
A Multi-Center, Double-Masked, Randomized, Controlled, Efficacy and Safety Study of EBI-005 5 mg/mL Topical Ophthalmic Solution Versus Vehicle Contraol In Subjects With Moderate to Severe Dry Eye Disease
Status: Enrolling
Updated: 7/10/2014
Clinical Research Facility
mi
from
Lexington, KY
Click here to add this to my saved trials
Phase 3 Study of EBI-005 in Dry Eye Disease
A Multi-Center, Double-Masked, Randomized, Controlled, Efficacy and Safety Study of EBI-005 5 mg/mL Topical Ophthalmic Solution Versus Vehicle Contraol In Subjects With Moderate to Severe Dry Eye Disease
Status: Enrolling
Updated:  7/10/2014
Clinical Research Facility
mi
from
Louisville, KY
Phase 3 Study of EBI-005 in Dry Eye Disease
A Multi-Center, Double-Masked, Randomized, Controlled, Efficacy and Safety Study of EBI-005 5 mg/mL Topical Ophthalmic Solution Versus Vehicle Contraol In Subjects With Moderate to Severe Dry Eye Disease
Status: Enrolling
Updated: 7/10/2014
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
Phase 3 Study of EBI-005 in Dry Eye Disease
A Multi-Center, Double-Masked, Randomized, Controlled, Efficacy and Safety Study of EBI-005 5 mg/mL Topical Ophthalmic Solution Versus Vehicle Contraol In Subjects With Moderate to Severe Dry Eye Disease
Status: Enrolling
Updated:  7/10/2014
Clinical Research Facility
mi
from
Winchester, MA
Phase 3 Study of EBI-005 in Dry Eye Disease
A Multi-Center, Double-Masked, Randomized, Controlled, Efficacy and Safety Study of EBI-005 5 mg/mL Topical Ophthalmic Solution Versus Vehicle Contraol In Subjects With Moderate to Severe Dry Eye Disease
Status: Enrolling
Updated: 7/10/2014
Clinical Research Facility
mi
from
Winchester, MA
Click here to add this to my saved trials
Phase 3 Study of EBI-005 in Dry Eye Disease
A Multi-Center, Double-Masked, Randomized, Controlled, Efficacy and Safety Study of EBI-005 5 mg/mL Topical Ophthalmic Solution Versus Vehicle Contraol In Subjects With Moderate to Severe Dry Eye Disease
Status: Enrolling
Updated:  7/10/2014
Clinical Research Facility
mi
from
Des Peres, MO
Phase 3 Study of EBI-005 in Dry Eye Disease
A Multi-Center, Double-Masked, Randomized, Controlled, Efficacy and Safety Study of EBI-005 5 mg/mL Topical Ophthalmic Solution Versus Vehicle Contraol In Subjects With Moderate to Severe Dry Eye Disease
Status: Enrolling
Updated: 7/10/2014
Clinical Research Facility
mi
from
Des Peres, MO
Click here to add this to my saved trials
Phase 3 Study of EBI-005 in Dry Eye Disease
A Multi-Center, Double-Masked, Randomized, Controlled, Efficacy and Safety Study of EBI-005 5 mg/mL Topical Ophthalmic Solution Versus Vehicle Contraol In Subjects With Moderate to Severe Dry Eye Disease
Status: Enrolling
Updated:  7/10/2014
Clinical Research Facility
mi
from
Norfolk, VA
Phase 3 Study of EBI-005 in Dry Eye Disease
A Multi-Center, Double-Masked, Randomized, Controlled, Efficacy and Safety Study of EBI-005 5 mg/mL Topical Ophthalmic Solution Versus Vehicle Contraol In Subjects With Moderate to Severe Dry Eye Disease
Status: Enrolling
Updated: 7/10/2014
Clinical Research Facility
mi
from
Norfolk, VA
Click here to add this to my saved trials
Phase 3 Study of EBI-005 in Dry Eye Disease
A Multi-Center, Double-Masked, Randomized, Controlled, Efficacy and Safety Study of EBI-005 5 mg/mL Topical Ophthalmic Solution Versus Vehicle Contraol In Subjects With Moderate to Severe Dry Eye Disease
Status: Enrolling
Updated:  7/10/2014
Clinical Research Facility
mi
from
St. Louis, MO
Phase 3 Study of EBI-005 in Dry Eye Disease
A Multi-Center, Double-Masked, Randomized, Controlled, Efficacy and Safety Study of EBI-005 5 mg/mL Topical Ophthalmic Solution Versus Vehicle Contraol In Subjects With Moderate to Severe Dry Eye Disease
Status: Enrolling
Updated: 7/10/2014
Clinical Research Facility
mi
from
St. Louis, MO
Click here to add this to my saved trials
Phase 3 Study of EBI-005 in Dry Eye Disease
A Multi-Center, Double-Masked, Randomized, Controlled, Efficacy and Safety Study of EBI-005 5 mg/mL Topical Ophthalmic Solution Versus Vehicle Contraol In Subjects With Moderate to Severe Dry Eye Disease
Status: Enrolling
Updated:  7/10/2014
Clinical Research Facility
mi
from
Washington, MO
Phase 3 Study of EBI-005 in Dry Eye Disease
A Multi-Center, Double-Masked, Randomized, Controlled, Efficacy and Safety Study of EBI-005 5 mg/mL Topical Ophthalmic Solution Versus Vehicle Contraol In Subjects With Moderate to Severe Dry Eye Disease
Status: Enrolling
Updated: 7/10/2014
Clinical Research Facility
mi
from
Washington, MO
Click here to add this to my saved trials
Phase 3 Study of EBI-005 in Dry Eye Disease
A Multi-Center, Double-Masked, Randomized, Controlled, Efficacy and Safety Study of EBI-005 5 mg/mL Topical Ophthalmic Solution Versus Vehicle Contraol In Subjects With Moderate to Severe Dry Eye Disease
Status: Enrolling
Updated:  7/10/2014
Clinical Research Facility
mi
from
Las Vegas, NV
Phase 3 Study of EBI-005 in Dry Eye Disease
A Multi-Center, Double-Masked, Randomized, Controlled, Efficacy and Safety Study of EBI-005 5 mg/mL Topical Ophthalmic Solution Versus Vehicle Contraol In Subjects With Moderate to Severe Dry Eye Disease
Status: Enrolling
Updated: 7/10/2014
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Phase 3 Study of EBI-005 in Dry Eye Disease
A Multi-Center, Double-Masked, Randomized, Controlled, Efficacy and Safety Study of EBI-005 5 mg/mL Topical Ophthalmic Solution Versus Vehicle Contraol In Subjects With Moderate to Severe Dry Eye Disease
Status: Enrolling
Updated:  7/10/2014
Clinical Research Facility
mi
from
Rochester, NY
Phase 3 Study of EBI-005 in Dry Eye Disease
A Multi-Center, Double-Masked, Randomized, Controlled, Efficacy and Safety Study of EBI-005 5 mg/mL Topical Ophthalmic Solution Versus Vehicle Contraol In Subjects With Moderate to Severe Dry Eye Disease
Status: Enrolling
Updated: 7/10/2014
Clinical Research Facility
mi
from
Rochester, NY
Click here to add this to my saved trials